What are the risks of investing in MPLT?
M
What are the risks of investing in MPLT?
🦉
MapLight Therapeutics, Inc. (MPLT)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOChristopher A. Kroeger
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and...
Key Executives
| Name | Title |
|---|---|
| Anatol Kreitzer | Chief Discovery Officer |
| Christopher A. Kroeger | Founder, President, Chief Executive Officer & Director |
| Erin Pennock Foff | Chief Medical Officer |
| James Woodruff Lillie | Chief Scientific Officer |
| Jonathan Gillis | Chief Administrative & Accounting Officer |
| Karl Deisseroth | Co-Founder & Member of Scientific Advisory Board |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A